CANY
AXNX

Caxton Associates (New York)’s Axonics, Inc. Common Stock AXNX Stock Holding History

Caxton Associates (New York)’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,159
Closed -$2.03M – 707
2024
Q3 		$2.03M Sell
29,159
-30,000
-51% -$2.06M 0.08% 120
2024
Q2 		$3.98M Sell
59,159
-7,148
-11% -$482K 0.14% 82
2024
Q1 		$4.57M Buy
+66,307
New +$4.47M 0.26% 43

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caxton Associates (New York)'s AXNX Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 29,159 shares — an estimated $2.03M sold.

Caxton Associates (New York) first reported a position in AXNX in Q1 2024 and held it in 3 quarters. The position peaked at $4.57M in Q1 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 29,159 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $2.03M.
  • Caxton Associates (New York) first reported a position in Axonics, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • Caxton Associates (New York)'s Axonics, Inc. Common Stock position peaked at $4.57M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.